Natco Pharma Limited

Web: natcopharma.co.in NSE: NATCOPHARM BSE: 524816 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

784 17(-2%)

Near 52W Low of 779

Volume

5L as on 16, Oct

Open

982

High

1,406

Low

1,381

801

VWAP

785

52 Week High

1,215

52 Week Low

779

Viand Research Rating

Quality Score

5/100

Growth Score

0/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

14,042

No. of Shares

17.9

P/E

13.03

P/B

3.5

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

26.87

ROCE

Profit Growth

Listing Date

27-Dec-95

Rank/Sector Rank

#473/#47

Promoter Holding

49.41%

FII Holding

16.99%

DII Holding

5.63%

Price Chart

Price Performance

1 Week1%

1 Month3%

3 Months19%

6 Months28%

1 Year6%

YTD12%

Moving Average

5 Day SMA788

10 Day SMA798

20 Day SMA810

30 Day SMA813

50 Day SMA840

61 Day SMA856

80 Day SMA878

200 Day SMA934

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	797	787	792	800
Resistance 2	792	787	789	794
Resistance 1	789	786	787	791
Pivot Point	784	785	784	785
Support 1	780	784	781	783
Support 2	775	783	779	777
Support 3	772	783	775	774

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 49.41%	(-0.11) 49.41%	(0.01) 49.48%	(-0.11) 49.48%	(0.01) 49.56%	(-0.11) 49.56%	(0.01) 49.62%	(-0.11) 49.62%	(0.01) 49.71%	(0.01) 49.71%	(0.01) 49.71%	(0.01) 49.71%	(0.91) 49.76%	(0.01) 48.84%	(0.01) 48.82%	(0.01) 48.80%	(0.01) 48.80%	(0.01) 48.81%	(0.01) 48.86%	(0.01) 48.87%
FIIs	(-0.41) 16.99%	(2.21) 17.37%	(1.11) 15.16%	(-1.41) 14.09%	(-2.01) 15.52%	(-0.51) 17.49%	(0.41) 17.94%	(0.11) 17.51%	(1.31) 17.45%	(2.41) 16.14%	(0.91) 13.72%	(1.81) 12.82%	(-0.91) 11.03%	(0.21) 11.91%	(0.11) 11.73%	(0.01) 11.67%	(-0.31) 11.65%	(-0.31) 11.94%	(-0.31) 12.26%	(0.01) 12.53%
DIIs	(0.21) 5.63%	(0.11) 5.46%	(-0.51) 5.39%	(0.11) 5.87%	(0.21) 5.81%	(0.01) 5.64%	(-1.21) 5.59%	(-1.11) 6.75%	(-1.81) 7.86%	(-1.61) 9.69%	(-2.81) 11.26%	(-1.11) 14.01%	(-0.21) 15.15%	(0.51) 15.38%	(0.61) 14.93%	(-1.01) 14.30%	(-0.81) 15.30%	(-1.91) 16.15%	(0.31) 18.08%	(0.01) 17.78%
Public	27.97%	27.74%	29.97%	30.56%	29.12%	27.30%	26.88%	26.13%	24.99%	24.46%	25.32%	23.48%	24.08%	23.87%	24.53%	25.23%	24.25%	23.10%	20.80%	20.82%
No. of Shareholders	403,166	410,970	424,167	419,699	429,434	405,222	345,332	302,944	251,485	228,467	207,571	163,753	155,181	153,663	135,397	121,336	92,449	85,828	88,421	88,439

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	597	609	529	1264	1193	1157	408	1293	1237	965	625	930	1048	898	492	432	885	597	560	377	410
Sales Growth % (YoY)	-50%	-47.4%	29.7%	-2.2%	-3.6%	20%	-34.8%	38.9%	18%	23.5%	51.4%	165%	30.1%	50.4%	-12.1%	14.6%	115.6%	80.1%	57.8%	-53%	-27.2%
Sales Growth % (QoQ)	-2%	15.1%	-58.1%	6%	3.1%	183.6%	-68.4%	4.5%	28.2%	54.4%	-32.8%	-11.3%	16.7%	82.5%	13.9%	-51.2%	48.2%	6.6%	48.5%	-8%	-
Expenses	491	516	408	712	653	596	378	502	474	512	387	488	545	559	387	337	489	615	459	307	300
Operating Profit	106	92	120	552	540	561	29	791	763	453	238	442	504	339	106	95	395	-19	102	70	110
OPM %	18	15	23	44	45	48	7	61	62	47	38	48	48	38	22	22	45	-3	18	19	27
Other Income	48	73	55	93	60	62	168	51	40	36	30	25	15	29	21	20	34	14	30	38	17
Interest	10	10	8	12	3	9	3	3	4	4	4	3	3	3	4	4	4	7	5	4	2
Depreciation	43	46	42	48	54	94	44	42	40	52	40	40	40	41	42	42	40	38	36	35	34
Profit before tax	102	110	125	586	543	521	150	797	758	432	224	424	475	324	81	70	386	-50	91	70	91
Tax %	27	-91	15	15	15	18	17	17	16	19	14	15	15	15	23	19	17	2	12	7	18
Net Profit	75	210	107	501	464	428	125	661	636	349	192	360	405	276	62	57	320	-50	80	65	75
Net Profit Growth % (QoQ)	-64.3%	96.3%	-78.6%	8%	8.4%	242.4%	-81.1%	3.9%	82.2%	81.8%	-46.7%	-11.1%	46.7%	345.2%	8.8%	-82.2%	740%	-162.5%	23.1%	-13.3%	-
Net Profit Growth % (YoY)	-83.8%	-50.9%	-14.4%	-24.2%	-27%	22.6%	-34.9%	83.6%	57%	26.4%	209.7%	531.6%	26.6%	652%	-22.5%	-12.3%	326.7%	-	-	-	-
TTM Net Profit	893	1282	1500	1518	1678	1850	1771	1838	1537	1306	1233	1103	800	715	389	407	415	170	220	140	0
EPS in Rs	4.17	11.7	5.97	27.97	25.91	23.9	6.97	36.91	35.53	19.49	10.72	20.11	22.63	15.11	3.41	3.11	17.55	-2.77	4.41	3.57	4.11

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	3595	4094	3569	2351	1768	1654	1790	1986	2091	1958	1059	716	739	661
Sales Growth %	-12.2%	14.7%	51.8%	33%	6.9%	-7.6%	-9.9%	-5%	6.8%	84.9%	48%	15%	11.9%	26.1%
Expenses	2290	1950	1929	1506	1555	1236	1212	1170	1163	1266	778	487	560	511
Operating Profit	1305	2144	1640	845	213	418	578	816	928	692	281	229	179	150
OPM %	36	52	46	36	12	25	32	41	44	35	26	32	24	23
Other Income	281	321	102	86	95	101	124	130	39	13	13	-2	17	1
Interest	32	20	14	9	13	11	21	19	15	18	22	30	37	26
Depreciation	190	220	172	151	138	115	98	80	66	54	50	42	30	22
Profit before tax	1364	2226	1555	771	156	392	583	847	888	634	222	154	129	102
Tax %	6	17	16	17	11	21	19	21	21	22	20	1	24	36
Net Profit	1282	1850	1307	637	139	310	474	667	698	495	176	153	98	66
Net Profit Growth %	-30.7%	41.5%	105.2%	358.3%	-55.2%	-34.6%	-28.9%	-4.4%	41%	181.2%	15%	56.1%	48.5%	-
EPS in Rs	71.55	103.31	72.95	34.9	7.62	16.97	26.06	36.48	37.84	28.39	10.13	9.2	6.21	4.58
Dividend Payout %	7	6	13	16	59	31	26	17	22	24	12	11	16	17

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1776	1662	1196	784	58	184	422	699	476	330	190	125	144	61
Cash from Investing Activity	-2078	-1444	-960	-437	-92	-3	-165	-645	-1131	-291	-248	-148	-108	-111
Cash from Financing Activity	302	-212	-237	-347	36	-183	-261	-52	652	-46	151	23	-35	26
Net Cash Flow	0	6	-1	1	1	-3	-4	1	-3	-6	93	-1	0	-24

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	36	36	36	36	36	36	36	36	36	36	37	35	35	33	33	31
Reserves	8517	8614	7298	7114	5556	4666	4155	4055	3833	3527	3088	1665	1302	846	693	502
Borrowings	709	261	275	208	366	161	400	256	314	384	173	221	110	309	240	338
Other Liabilities	1026	1520	661	886	596	525	387	405	463	408	438	427	396	207	229	209
Total Liabilities	10287	10430	8270	8245	6554	5388	4978	4752	4647	4356	3736	2347	1843	1395	1196	1080
Fixed Assets	2615	2697	2517	2541	2287	2234	2174	2006	1574	1215	1015	829	706	573	645	583
CWIP	293	255	225	234	134	63	129	223	518	638	480	336	212	101	124	106
Investments	3265	774	855	643	742	658	550	337	191	244	150	95	94	131	2	2
Other Assets	4114	6704	4673	4826	3392	2434	2125	2186	2363	2259	2091	1087	831	590	425	389
Total Assets	10287	10430	8270	8245	6554	5388	4978	4752	4647	4356	3736	2347	1843	1395	1196	1080

Delivery

Delivery Data: NATCOPHARM

#	Date	779 24% 965	Value (Cr)	Q/T 17	Del 45	Del 26
1	21-Oct	784	38	16	51	19
2	19-Oct	801	61	19	27	17
3	16-Oct	785	39	25	73	29
4	15-Oct	785	23	21	65	15
5	14-Oct	783	37	15	58	21
6	13-Oct	789	22	13	59	13
7	12-Oct	801	40	25	66	26
8	9-Oct	789	18	8	49	9
9	8-Oct	795	25	8	54	13
10	7-Oct	810	41	17	56	23
11	6-Oct	824	18	13	62	11
12	5-Oct	822	46	16	56	26
13	1-Oct	821	59	12	55	33
14	30-Sep	828	51	9	65	33
15	29-Sep	843	54	10	46	25
16	28-Sep	829	42	11	55	23
17	25-Sep	839	31	15	44	14
18	24-Sep	842	44	18	39	18
19	23-Sep	838	54	16	51	27
20	22-Sep	815	50	18	55	28
21	21-Sep	816	37	11	60	22
22	18-Sep	813	40	15	61	24
23	17-Sep	818	28	11	49	13
24	16-Sep	813	40	13	51	20
25	15-Sep	819	36	14	49	17
26	11-Sep	815	46	16	57	26
27	10-Sep	819	19	9	54	10
28	9-Sep	826	44	15	38	17
29	8-Sep	826	25	12	61	15
30	7-Sep	838	25	12	52	13
31	4-Sep	829	37	13	60	22
32	3-Sep	838	18	9	53	10
33	2-Sep	843	40	12	53	21
34	1-Sep	849	20	10	54	11
35	31-Aug	842	35	11	61	21
36	28-Aug	854	34	13	57	20
37	27-Aug	858	24	11	50	12
38	26-Aug	863	32	15	47	15
39	25-Aug	866	39	12	60	23
40	24-Aug	884	28	13	41	11
41	21-Aug	882	32	15	35	11
42	20-Aug	878	24	15	49	12
43	19-Aug	887	29	11	44	13
44	18-Aug	898	25	13	42	11
45	17-Aug	890	75	17	38	29
46	14-Aug	903	227	24	17	39
47	13-Aug	952	114	21	37	42
48	12-Aug	915	25	15	53	13

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	14,042c	340c	2.37
19-Oct	14,383c	307c	2.18
17-Oct	14,075c	0	0
16-Oct	14,075c	12c	0.08
15-Oct	14,064c	71c	0.50
14-Oct	14,135c	12c	0.08
13-Oct	14,123c	206c	1.44
12-Oct	14,329c	144c	1.02
09-Oct	14,185c	51c	0.36
08-Oct	14,236c	401c	2.74
05-Oct	14,637c	146c	0.99
01-Oct	14,783c	243c	1.62
29-Sep	15,026c	195c	1.32
28-Sep	14,830c	236c	1.57
25-Sep	15,067c	193c	1.27
24-Sep	15,260c	647c	4.42
22-Sep	14,614c	91c	0.62
17-Sep	14,523c	138c	0.94
10-Sep	14,661c	327c	2.18
07-Sep	14,988c	136c	0.92
04-Sep	14,852c	0	0

Stock Checklist

Price is above from 52 week high low average: 1%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 104 fund scheme(s) across 23 fund house(s) as of Oct26 · Total value ₹614 Cr · 20 increasing / 20 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Tata Mutual Fund	10	0.65%	+0.31%	304.3
Sundaram Mutual Fund	2	1.11%	-0.01%	91.3
Bandhan Mutual Fund	8	0.73%	-	47.2
Aditya Birla Sun Life Mutual Fund	4	0.91%	-0.01%	26.2
Nippon India Mutual Fund	6	0.32%	-0.01%	25.6
quant Mutual Fund	2	3.20%	+3.01%	25.6
Axis Mutual Fund	6	0.65%	-0.04%	15.3
ICICI Prudential Mutual Fund	8	0.08%	-0.11%	14.9
SBI Mutual Fund	4	0.25%	-0.01%	12.2
Motilal Oswal Mutual Fund	8	0.13%	-0.01%	11.9
DSP Mutual Fund	6	1.37%	+0.04%	9.2
JM Financial Mutual Fund	2	0.48%	+0.02%	7.4
Edelweiss Mutual Fund	4	0.39%	-	6.8
HDFC Mutual Fund	6	0.19%	-0.01%	6.1
Kotak Mahindra Mutual Fund	4	0.74%	-0.04%	5.1
Jio BlackRock Mutual Fund	3	0.04%	-0.01%	1.4
Groww Mutual Fund	4	0.12%	-0.01%	1.2
UTI Mutual Fund	2	0.28%	+0.01%	0.7
Navi Mutual Fund	6	0.39%	-	0.6
Angel One Mutual Fund	4	0.16%	-0.03%	0.3
Mirae Asset Mutual Fund	2	0.04%	-	0
Zerodha Mutual Fund	1	0.16%	-0.02%	0
The Wealth Company Mutual Fund	2	0.00%	-1.38%	0

Natco Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements